Literature DB >> 8761502

The distribution of antibodies to streptokinase.

M Lynch1, B L Pentecost, W A Littler, R A Stockley.   

Abstract

To determine the distribution of antibodies to streptokinase that might be anticipated in patients requiring treatment with streptokinase, specific anti-streptokinase antibody titres were determined in a group of subjects from the general population and in a group of patients presenting with acute myocardial infarction. Enzyme-linked immunosorbent assays were developed to measure specific anti-streptokinase IgG and subclass IgG1 in 95 subjects from the general population and in 160 patients presenting with acute myocardial infarction. Low titres of IgG1 were found in both the general population (median = 5; range: 0-490) and in the myocardial infarction group (median = 7; range: 0-2000). A minority of subjects in both groups had high titres. The findings suggest that low titres of antibody are widespread in the population. The minority of subjects in both groups who had high titres may explain the infrequent type III immune reactions encountered with streptokinase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761502      PMCID: PMC2398450          DOI: 10.1136/pgmj.72.847.290

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

1.  Proceedings: A controlled study of the diuretic and natriuretic properties of perhexiline maleate in normal human volunteers.

Authors:  A W Czerwinski; T L Whitsett; A B Czerwinski; M L Clark
Journal:  Postgrad Med J       Date:  1973-04       Impact factor: 2.401

2.  IgG1 is the predominant subclass of in vivo- and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells.

Authors:  R Stevens; D Dichek; B Keld; D Heiner
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

3.  Rapid detection and quantitation of precipitating streptokinase-antibodies.

Authors:  F Spöttl; R Kaiser
Journal:  Thromb Diath Haemorrh       Date:  1974-12-31

4.  Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.

Authors:  M Lynch; W A Littler; B L Pentecost; R A Stockley
Journal:  Br Heart J       Date:  1991-08

5.  Why do patients develop reactions to streptokinase?

Authors:  M Lynch; B L Pentecost; W A Littler; R A Stockley
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

6.  The significance of anti-streptokinase antibodies.

Authors:  M Lynch; B L Pentecost; W A Littler; R A Stockley
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

  6 in total
  3 in total

1.  Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection.

Authors:  N Blackwell; A Hollins; G Gilmore; R Norton
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

Review 2.  Current methods for detecting antibodies against erythropoietin and other recombinant proteins.

Authors:  Robin Thorpe; Steven J Swanson
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

3.  Antistreptokinase antibodies and the response to thrombolysis with streptokinase in patients with acute ST elevation myocardial infarction.

Authors:  M S K Subhendu; Oommen K George; John A Jude Prakash
Journal:  Heart Asia       Date:  2012-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.